Navigation Links
American Medical Association Clears Path for Adenoviral Conjunctivitis - 'Pink Eye' - Detector

SARASOTA, Fla., Nov. 7 /PRNewswire/ -- Rapid Pathogen Screening Inc., (RPS) -- a leading developer of point-of-care diagnostic devices for ocular diseases -- announced today that the American Medical Association will issue a new Current Procedural Terminology (CPT) code that will cover the RPS Adeno Detector(TM), effective January 1, 2008. CPT Code 87809 -- a code for "Infectious agent antigen detection by immunoassay with direct optical observation; Adenovirus" -- will cover the RPS Adeno Detector(TM).

The RPS Adeno Detector(TM) is the first true point-of-care test available for conjunctivitis -- more commonly known as "pink eye." Cleared by the Food and Drug Administration (FDA) and waived under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), this test is highly sensitive and specific, and it provides a definitive result in 10 minutes. The publication of this CPT code will expand the use of the RPS Adeno Detector(TM) and equip health care providers with this necessary tool to make an accurate laboratory confirmation of adenoviral conjunctivitis at the time of the patient exam.

"The creation of a new CPT code reflects the value that the RPS Adeno Detector(TM) provides to the patient, the clinician and the healthcare system at large," stated Robert Sambursky, MD, Chief Medical Officer of RPS. "With the CPT code, clinicians may use the RPS Adeno Detector(TM) to accurately diagnose and treat cases of acute conjunctivitis. This will not only result in better patient care; it also will save millions in health care dollars. If all cases of acute conjunctivitis were diagnosed with the RPS Adeno Detector(TM), the Health Economics Consulting Group, LLC (HECG) estimates that the U.S. healthcare system would save more than $460 million each year."

The RPS Adeno Detector(TM) not only allows for accurate and early diagnosis of pink eye thereby mitigating the spread of this often contagious disease, but it also reduces the over-prescription of antibiotics -- to which Americans have become more resistant as documented by recent medical reports.

About the RPS Adeno Detector(TM)

The RPS Adeno Detector(TM) is the first in a family of RPS point-of-care diagnostic devices. As a rapid, in-office, immunodiagnostic test for detecting the presence of adenoviral antigens, the RPS Adeno Detector(TM) meets the criteria established within the October 2006 Preferred Practice Pattern(TM) on Conjunctivitis from the American Academy of Ophthalmology. The test is currently being used as point-of-care test in many optometry and ophthalmology offices, family practice and pediatric offices, as well as on military bases and other centers for care across the United States.

About the Code

CPT codes are published by the American Medical Association, and each code is a five digit numeric code used to provide uniform language that accurately describes medical, surgical, radiology, laboratory, anesthesiology, and evaluation/management services of physicians, hospitals, and other health care providers. There are approximately 7,800 CPT codes.

About RPS:

To learn more about RPS, please visit:

Contact: Dan Maloy

Rapid Pathogen Screening, Inc.


SOURCE Rapid Pathogen Screening Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology: